Hjelmevoll Stig Ove, Olsen Merethe Elise, Sollid Johanna U Ericson, Haaheim Håkon, Melby Kjetil K, Moi Harald, Unemo Magnus, Skogen Vegard
Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway.
Sex Transm Dis. 2008 May;35(5):517-20. doi: 10.1097/OLQ.0b013e3181644bc9.
Diagnosing Neisseria gonorrheae using nucleic acid amplification tests (NAATs) might increase the sensitivity, compared to cultivation. However, using NAATs has also been problematic mainly due to the close genetic relationships between different Neisseria species, resulting in false positive diagnoses. This study was conducted to clinically validate a previously published real-time polymerase chain reaction (PCR) method targeting the porA pseudogene in N. gonorrheae in comparison to culture techniques.
In total, 360 samples, urethra (n = 109), rectum (n = 84), pharynx (n = 119), and cervix (n = 48) from 185 males and 57 females, were analyzed using porA pseudogene PCR and cultivation. Sequencing of the entire porA pseudogene and the 16S rRNA gene were used to resolve discrepant results.
Of the 360 samples, 37 were positive by both culture and PCR, however, the PCR identified 15 additional confirmed positive samples. The PCR method showed a sensitivity, specificity, positive predictive value, and negative predictive value of 100% in a preselected population. The preselected population had a true gonorrhea prevalence of 17.4%.
The present porA pseudogene real-time PCR comprises a valuable supplement to the traditional culture techniques for diagnosis of N. gonorrheae, especially for samples from extragenital sites such as pharynx and rectum.
与培养法相比,使用核酸扩增试验(NAATs)诊断淋病奈瑟菌可能会提高敏感性。然而,使用NAATs也存在问题,主要是因为不同奈瑟菌属之间的遗传关系密切,导致假阳性诊断。本研究旨在与培养技术相比,对先前发表的针对淋病奈瑟菌中porA假基因的实时聚合酶链反应(PCR)方法进行临床验证。
总共对来自185名男性和57名女性的360份样本进行分析,这些样本包括尿道(n = 109)、直肠(n = 84)、咽(n = 119)和宫颈(n = 48),采用porA假基因PCR和培养法进行检测。对整个porA假基因和16S rRNA基因进行测序,以解决结果不一致的问题。
在360份样本中,37份通过培养和PCR均呈阳性,然而,PCR还额外鉴定出15份确诊阳性样本。在预先选定的人群中,PCR方法的敏感性、特异性、阳性预测值和阴性预测值均为100%。预先选定人群的淋病实际患病率为17.4%。
目前的porA假基因实时PCR是传统培养技术诊断淋病奈瑟菌的有价值补充,特别是对于来自咽和直肠等生殖器外部位的样本。